Efficacy of epratuzumab, an anti‐CD22 monoclonal igG antibody, in systemic lupus erythematosus patients with associated Sjögren's syndrome: post‐hoc analyses from the EMBODY trials
Jacques-Eric Gottenberg, Thomas Dörner, Hendrika Bootsma, Valérie Devauchelle‐Pensec, Simon J. Bowman, Xavier Mariette, Holger Bartz, Marga Oortgiesen, Anthony Shock, Willem Koetse, Catrinel Galateanu, Sabine Bongardt, William A. Wegener, David M. Goldenberg, Guy Meno‐Tetang, Gordana Kosutic, Caroline Gordon
Research output: Contribution to journal › Article › peer-review
26Citations
(Scopus)
194Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Efficacy of epratuzumab, an anti‐CD22 monoclonal igG antibody, in systemic lupus erythematosus patients with associated Sjögren's syndrome: post‐hoc analyses from the EMBODY trials'. Together they form a unique fingerprint.